The nail psoriasis treatment market is projected to grow from USD 2.0 billion in 2026 to USD 4.8 billion by 2036, at a CAGR of 9.1%. Topical corticosteroids will dominate with a 32.0% market share, while dermatology clinics will lead the treatment settings segment with a 46.0% share.